|
ALBO
|
Albireo Pharma, Inc.
|
US
|
NASDAQ
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BLTE
|
Belite Bio, Inc.
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
|
HEPA
|
Hepion Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TARA
|
ArTara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AJJ
|
Asian American Medical Group Ltd
|
AU
|
ASX
|
|
VBS
|
Vectus Biosystems Ltd
|
AU
|
ASX
|
|
CHSYF
|
China Medical Sys Hlds
|
US
|
OTC
|
|
ISCO
|
International Stem Cell Corp
|
US
|
OTC
|
|
MVRBF
|
Medivir Ser B Sek5
|
US
|
OTC
|
|
SEQUA
|
Sequana Medical NV
|
BE
|
BR
|
|
532321
|
Cadila Healthcare Limited
|
IN
|
BSE
|
|
3G0
|
Altimmune Inc
|
DE
|
F
|